MedTrace Logo

The Effect of Probiotics on Oral Health

NCT05039320 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2021-11-16

No results posted yet for this study

Summary

This will be a double-blind, randomized, placebo-controlled two-arm parallel groups study of the effect of oral probiotics containing Streptococcus salivarius K12 on oral biofilm, salivation rate, and secretory immunoglobulin A salivary level.

The aim of the study is to assess the effect of oral probiotics containing Streptococcus salivarius K12 strain on oral biofilm, unstimulated salivary flow rate, and salivary secretory immunoglobulin A (sIgA) levels.

Conditions

  • Oral Disease

Interventions

DIETARY_SUPPLEMENT

Bactoblis

dissolve the tablets in the mouth once a day for 4 weeks

DIETARY_SUPPLEMENT

Placebo

dissolve the tablets in the mouth once a day for 4 weeks

Sponsors & Collaborators

  • I. Mechnikov Research Institute of Vaccines and Sera

    collaborator UNKNOWN

  • I.M. Sechenov First Moscow State Medical University

    lead OTHER

Principal Investigators

  • Ksenia Babina, PhD · Sechenov University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-09-02
Primary Completion
2021-10-28
Completion
2021-11-04

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05039320 on ClinicalTrials.gov